1
|
Edwards D, Voronina A, Attwood K, Grand’Maison A. Association between occupational exposures and sarcoma incidence and mortality: systematic review and meta-analysis. Syst Rev 2021; 10:231. [PMID: 34389054 PMCID: PMC8364027 DOI: 10.1186/s13643-021-01769-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/29/2020] [Accepted: 07/21/2021] [Indexed: 01/11/2023] Open
Abstract
BACKGROUND Sarcomas are a rare and heterogeneous group of tumors originating from mesenchymal or connective tissue. They represent less than 1% of all adult cancers. The etiology and epidemiology of sarcomas remain understudied and poorly understood. The main objective of our study was to systematically assess the association between various occupational exposures and risk of sarcomas. METHODS We performed a systematic literature search using the PubMed, Scopus, EMBASE and Cochrane databases to identify relevant cohort and case-control studies. A meta-analysis method was applied on the incidence and mortality outcomes where the estimate with 95% confidence interval (CI) was obtained. RESULTS We included a total of 50 publications in our systematic review and 35 in meta-analysis. For exposures to phenoxy herbicides and chlorophenols, the pooled odds ratio (OR) for sarcoma was 1.85 (95% CI: 1.22, 2.82), based on 16 studies with 2254 participants, while the pooled standardized mortality ratio was 40.93 (95% CI 2.19, 765.90), based on 4 cohort studies with 59,289 participants. For exposure to vinyl chloride monomers the pooled risk ratios for angiosarcoma of the liver and other STS were 19.23 (95% CI 2.03, 182.46) and 2.23 (95 CI 1.55, 3.22) respectively based on 3 cohort studies with 12,816 participants. Exposure to dioxins was associated with an increased STS mortality; the pooled standardized mortality ratio was 2.56 (95% CI 1.60, 4.10) based on 4 cohort studies with 30,797 participants. Finally, woodworking occupation was associated with an increased risk of STS with the pooled OR of 2.16 (95% CI 1.39, 3.36). CONCLUSIONS Our findings suggest a positive association between higher exposure to dioxins and increased mortality from STS, between cumulative exposure to vinyl chloride monomers and increased mortality from angiosarcoma of the liver and STS, and between woodworking occupation and STS incidence. These findings were all statistically significant.
Collapse
Affiliation(s)
- D. Edwards
- State University of New York At Buffalo, Department of Medicine, 12 Capen Hall, Buffalo, NY 14260 USA
| | - A. Voronina
- New York- Presbyterian Queens, Department of Medicine, 56-45 Main St, Flushing, NY 11355 USA
| | - K. Attwood
- Department of Biostatistics, Roswell Park Comprehensive Cancer Center, 665 Elm Street, Buffalo, NY 14203 USA
| | - A. Grand’Maison
- Department of Sarcoma Medical Oncology, Roswell Park Comprehensive Cancer Center, 665 Elm Street, Buffalo, NY 14203 USA
| |
Collapse
|
2
|
Boice JD, Cohen SS, Mumma MT, Golden AP, Howard SC, Girardi DJ, Ellis ED, Bellamy MB, Dauer LT, Samuels C, Eckerman KF, Leggett RW. Mortality among workers at the Los Alamos National Laboratory, 1943-2017. Int J Radiat Biol 2021; 98:722-749. [PMID: 34047625 DOI: 10.1080/09553002.2021.1917784] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
BACKGROUND During World War II (WWII), the Manhattan Engineering District established a secret laboratory in the mountains of northern New Mexico. The mission was to design, construct and test the first atomic weapon, nicknamed 'The Gadget' that was detonated at the TRINITY site in Alamogordo, NM. After WWII, nuclear weapons research continued, and the laboratory became the Los Alamos National Laboratory (LANL). MATERIALS AND METHODS The mortality experience of 26,328 workers first employed between 1943 and 1980 at LANL was determined through 2017. Included were 6157 contract workers employed by the ZIA Company. Organ dose estimates for each worker considered all sources of exposure, notably photons, neutrons, tritium, 238Pu and 239Pu. Vital status determination included searches within the National Death Index, Social Security Administration and New Mexico State Mortality Files. Standardized Mortality Ratios (SMR) and Cox regression models were used in the analyses. RESULTS Most workers (55%) were hired before 1960, 38% had a college degree, 25% were female, 81% white, 13% Hispanic and 60% had died. Vital status was complete, with only 0.1% lost to follow-up. The mean dose to the lung for the 17,053 workers monitored for radiation was 28.6 weighted-mGy (maximum 16.8 weighted-Gy) assuming a Dose Weighting Factor of 20 for alpha particle dose to lung. The Excess Relative Risk (ERR) at 100 weighted-mGy was 0.01 (95%CI -0.02, 0.03; n = 839) for lung cancer. The ERR at 100 mGy was -0.43 (95%CI -1.11, 0.24; n = 160) for leukemia other than chronic lymphocytic leukemia (CLL), -0.06 (95%CI -0.16, 0.04; n = 3043) for ischemic heart disease (IHD), and 0.29 (95%CI 0.02, 0.55; n = 106) for esophageal cancer. Among the 6499 workers with measurable intakes of plutonium, an increase in bone cancer (SMR 2.44; 95%CI 0.98, 5.03; n = 7) was related to dose. The SMR for berylliosis was significantly high, based on 4 deaths. SMRs for Hispanic workers were significantly high for cancers of the stomach and liver, cirrhosis of the liver, nonmalignant kidney disease and diabetes, but the excesses were not related to radiation dose. CONCLUSIONS There was little evidence that radiation increased the risk of lung cancer or leukemia. Esophageal cancer was associated with radiation, and plutonium intakes were linked to an increase of bone cancer. IHD was not associated with radiation dose. More precise evaluations will await the pooled analysis of workers with similar exposures such as at Rocky Flats, Savannah River and Hanford.
Collapse
Affiliation(s)
- John D Boice
- National Council on Radiation Protection and Measurements, Bethesda, MD, USA.,Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA
| | | | - Michael T Mumma
- International Epidemiology Institute, Rockville, MD, USA.,International Epidemiology Field Station, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Ashley P Golden
- ORISE Health Studies Program, Oak Ridge Associated Universities, Oak Ridge, TN, USA
| | - Sara C Howard
- ORISE Health Studies Program, Oak Ridge Associated Universities, Oak Ridge, TN, USA
| | - David J Girardi
- ORISE Health Studies Program, Oak Ridge Associated Universities, Oak Ridge, TN, USA
| | | | - Michael B Bellamy
- Department of Medical Physics and Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Lawrence T Dauer
- Department of Medical Physics and Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | | | | | | |
Collapse
|
3
|
The effects of chronic diseases on plutonium urinary excretion in former workers of the Mayak Production Association. PLoS One 2020; 15:e0242151. [PMID: 33186401 PMCID: PMC7665703 DOI: 10.1371/journal.pone.0242151] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2020] [Accepted: 10/27/2020] [Indexed: 01/04/2023] Open
Abstract
The radiochemical analysis of plutonium activity in urine is the main method for indirect estimation of doses of internal exposure from plutonium incorporation in professional workers. It was previously shown that late-in-life acute diseases, particularly those that affect the liver, can promote accelerated rates of release of plutonium from the liver with enhanced excretion rates. This initial study examines the relationships of some chronic diseases on plutonium excretion as well as the terminal relative distribution of plutonium between the liver and skeleton. Fourteen cases from former workers at the Mayak Production Association (Mayak PA) who provided from 4–9 urine plutonium bioassays for plutonium, had an autopsy conducted after death, and had sufficient clinical records to document their health status were used in this study. Enhanced plutonium excretion was associated with more serious chronic diseases, including cardiovascular diseases and other diseases that involved the liver. These chronic diseases were also associated with relatively less plutonium found in the liver relative to the skeleton determined by analyses conducted after autopsy. These data further document health conditions that affect plutonium biokinetics and organ deposition and retention patterns and suggest that health status should be considered when conducting plutonium bioassays as these may alter subsequent dosimetry and risk models.
Collapse
|
4
|
Goerlitz DS, Blancato J, Ramesh A, Islam M, Graham GT, Revina V, Kallakury B, Zeck J, Kirillova E, Loffredo CA. Somatic mutation signatures in primary liver tumors of workers exposed to ionizing radiation. Sci Rep 2019; 9:18199. [PMID: 31796844 PMCID: PMC6890664 DOI: 10.1038/s41598-019-54773-z] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2018] [Accepted: 11/18/2019] [Indexed: 01/04/2023] Open
Abstract
Liver cancer is associated with genetic mutations caused by environmental exposures, including occupational exposure to alpha radiation emitted by plutonium. We used whole exome sequencing (WES) to characterize somatic mutations in 3 histologically distinct primary liver tumors (angiosarcoma of the liver (ASL), cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC)) from Mayak worker subjects occupationally exposed to ionizing radiation (IR) to investigate the contribution of IR to the mutational landscape of liver cancer. DNA sequence analysis revealed these tumors harbor an excess of deletions, with a deletions:substitutions ratio similar to that previously reported in radiation-associated tumors. These tumors were also enriched for clustered mutations, a signature of radiation exposure. Multiple tumors displayed similarities in abrogated gene pathways including actin cytoskeletal signaling and DNA double-strand break (DSB) repair. WES identified novel candidate driver genes in ASL involved in angiogenesis and PIK3CA/AKT/mTOR signaling. We confirmed known driver genes of CCA, and identified candidate driver genes involved in chromatin remodeling. In HCC tumors we validated known driver genes, and identified novel putative driver genes involved in Wnt/β-catenin signaling, chromatin remodeling, PIK3CA/AKT/mTOR signaling, and angiogenesis. This pilot study identifies several novel candidate driver mutations that are likely to be caused by IR exposure, and provides the first data on the mutational landscape of liver cancer after IR exposure.
Collapse
Affiliation(s)
- David S Goerlitz
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA
| | - Jan Blancato
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA
| | - Archana Ramesh
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA
| | - Md Islam
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA
| | - Garrett T Graham
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA
| | - Valentina Revina
- Russian Radiobiology Human Tissue Repository, Southern Urals Biophysics Institute, Ozyorsk, Chelyabinsk Oblast, Russian Federation
| | - Bhaskar Kallakury
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA
| | - Jay Zeck
- Department of Pathology, Georgetown University, Washington, District of Columbia, USA
| | - Evgeniya Kirillova
- Russian Radiobiology Human Tissue Repository, Southern Urals Biophysics Institute, Ozyorsk, Chelyabinsk Oblast, Russian Federation
| | - Christopher A Loffredo
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
| |
Collapse
|
5
|
Azizova TV, Bannikova MV, Grigoryeva ES, Rybkina VL. Risk of malignant skin neoplasms in a cohort of workers occupationally exposed to ionizing radiation at low dose rates. PLoS One 2018; 13:e0205060. [PMID: 30289933 PMCID: PMC6173419 DOI: 10.1371/journal.pone.0205060] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2018] [Accepted: 09/19/2018] [Indexed: 12/01/2022] Open
Abstract
Recently an increasing trend in skin cancer rates has been observed in various populations including those exposed to different radiation types. Risk and dose-response following prolonged radiation exposure remain unclear. The present study was aimed to assess skin melanoma (SM) and non-melanoma skin cancer (NMSC) incidence risks in a cohort of workers occupationally exposed to ionizing radiation at low dose rates over prolonged periods. The study cohort included workers of a Russian nuclear production facility, Mayak Production Association (PA), who were first employed in 1948-1982 and followed up till the end of 2013 (the total of 22,377 individuals with 25% of females). Using AMFIT module of EPICURE software, relative risk and excess relative risk per unit dose (RR and ERR/Sv) were calculated. 60 SM and 294 NMSC cases were registered in members of the study cohort. SM and NMSC incidence was dependent on sex, attained age, age at first employment at the enterprise, type of facility, education level and was not dependent on calendar period of first employment, calendar period of diagnosis, duration of employment, smoking and alcohol consumption statuses. The risk of NMSC incidence was found to be significantly increased in workers occupationally exposed to ionizing radiation at cumulative doses above 2.0 Sv (RR = 2.52; 95% CI: 1.60, 3.97) compared to a reference dose category (0-0.05 Sv). NMSC incidence was found to be significantly associated with cumulative external gamma-dose with ERR/Sv of 0.49 (95% CI: 0.22, 0.90) without an adjustment for neutron dose and 0.51 (95% CI: 0.22, 0.93) while adjusted for neutron dose. Results of the analysis did not reveal a significant association of SM incidence with cumulative dose from external gamma-rays with ERR/Sv of 0.22 (95% CI: -0.29, 1.46) not including a neutron dose adjustment and of 0.15 (95% CI: -0.41, 1.31) while adjusted for dose from neutron exposure.
Collapse
Affiliation(s)
- Tamara V. Azizova
- Clinical Department, Southern Urals Biophysics Institute (SUBI), Ozyorsk, Chelyabinsk region, Russia
| | - Maria V. Bannikova
- Clinical Department, Southern Urals Biophysics Institute (SUBI), Ozyorsk, Chelyabinsk region, Russia
| | - Evgeniya S. Grigoryeva
- Clinical Department, Southern Urals Biophysics Institute (SUBI), Ozyorsk, Chelyabinsk region, Russia
| | - Valentina L. Rybkina
- Clinical Department, Southern Urals Biophysics Institute (SUBI), Ozyorsk, Chelyabinsk region, Russia
| |
Collapse
|
6
|
Grellier J, Atkinson W, Bérard P, Bingham D, Birchall A, Blanchardon E, Bull R, Guseva Canu I, Challeton-de Vathaire C, Cockerill R, Do MT, Engels H, Figuerola J, Foster A, Holmstock L, Hurtgen C, Laurier D, Puncher M, Riddell AE, Samson E, Thierry-Chef I, Tirmarche M, Vrijheid M, Cardis E. Risk of Lung Cancer Mortality in Nuclear Workers from Internal Exposure to Alpha Particle-emitting Radionuclides. Epidemiology 2017; 28:675-684. [PMID: 28520643 PMCID: PMC5540354 DOI: 10.1097/ede.0000000000000684] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2016] [Accepted: 05/15/2017] [Indexed: 11/26/2022]
Abstract
BACKGROUND Carcinogenic risks of internal exposures to alpha-emitters (except radon) are poorly understood. Since exposure to alpha particles-particularly through inhalation-occurs in a range of settings, understanding consequent risks is a public health priority. We aimed to quantify dose-response relationships between lung dose from alpha-emitters and lung cancer in nuclear workers. METHODS We conducted a case-control study, nested within Belgian, French, and UK cohorts of uranium and plutonium workers. Cases were workers who died from lung cancer; one to three controls were matched to each. Lung doses from alpha-emitters were assessed using bioassay data. We estimated excess odds ratio (OR) of lung cancer per gray (Gy) of lung dose. RESULTS The study comprised 553 cases and 1,333 controls. Median positive total alpha lung dose was 2.42 mGy (mean: 8.13 mGy; maximum: 316 mGy); for plutonium the median was 1.27 mGy and for uranium 2.17 mGy. Excess OR/Gy (90% confidence interval)-adjusted for external radiation, socioeconomic status, and smoking-was 11 (2.6, 24) for total alpha dose, 50 (17, 106) for plutonium, and 5.3 (-1.9, 18) for uranium. CONCLUSIONS We found strong evidence for associations between low doses from alpha-emitters and lung cancer risk. The excess OR/Gy was greater for plutonium than uranium, though confidence intervals overlap. Risk estimates were similar to those estimated previously in plutonium workers, and in uranium miners exposed to radon and its progeny. Expressed as risk/equivalent dose in sieverts (Sv), our estimates are somewhat larger than but consistent with those for atomic bomb survivors.See video abstract at, http://links.lww.com/EDE/B232.
Collapse
Affiliation(s)
- James Grellier
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Will Atkinson
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Philippe Bérard
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Derek Bingham
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Alan Birchall
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Eric Blanchardon
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Richard Bull
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Irina Guseva Canu
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Cécile Challeton-de Vathaire
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Rupert Cockerill
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Minh T. Do
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Hilde Engels
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Jordi Figuerola
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Adrian Foster
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Luc Holmstock
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Christian Hurtgen
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Dominique Laurier
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Matthew Puncher
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Anthony E. Riddell
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Eric Samson
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Isabelle Thierry-Chef
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Margot Tirmarche
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Martine Vrijheid
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Elisabeth Cardis
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| |
Collapse
|
7
|
Sokolnikov M, Preston D, Stram DO. Mortality from solid cancers other than lung, liver, and bone in relation to external dose among plutonium and non-plutonium workers in the Mayak Worker Cohort. RADIATION AND ENVIRONMENTAL BIOPHYSICS 2017; 56:121-125. [PMID: 27695960 PMCID: PMC9126197 DOI: 10.1007/s00411-016-0670-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2016] [Accepted: 09/17/2016] [Indexed: 05/21/2023]
Abstract
Exposure to ionizing radiation has well-documented long-term effects on cancer rates and other health outcomes in humans. While in vitro experimental studies had demonstrated that the nature of some radiation effects depend on both total dose of the radiation and the dose rate (i.e., the pattern of dose distribution over time), the question of whether or not the carcinogenic effect of radiation exposure depends on the dose rate remains unanswered. Another issue of interest concerns whether or not concomitant exposure to external gamma rays and inhaled plutonium aerosols has any effect on the external exposure effects. The analyses of the present paper focus on the risk of solid cancers at sites other than lung, liver, and bone in Mayak workers. Recent findings are reviewed indicating that there is no evidence of plutonium dose response for these cancers in the Mayak worker cohort. Then the evidence for differences in the external dose effects among workers with and without the potential for exposure to alpha particles from inhaled plutonium is examined. It is found that there is no evidence that exposure to plutonium aerosols significantly affects the risk associated with external exposure. While the Mayak external dose risk estimate of an excess relative risk of 0.16 per Gy is somewhat lower than an appropriately normalized risk estimate from the Life Span Study of Japanese atomic bomb survivors, the uncertainties in these estimates preclude concluding that the external dose excess relative risks of this group of solid cancers differ in the two cohorts.
Collapse
Affiliation(s)
| | - Dale Preston
- Hirosoft International Corporation, Eureka, CA, USA
| | - Daniel O Stram
- Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| |
Collapse
|
8
|
Niwa O, Barcellos-Hoff MH, Globus RK, Harrison JD, Hendry JH, Jacob P, Martin MT, Seed TM, Shay JW, Story MD, Suzuki K, Yamashita S. ICRP Publication 131: Stem Cell Biology with Respect to Carcinogenesis Aspects of Radiological Protection. Ann ICRP 2016; 44:7-357. [PMID: 26637346 DOI: 10.1177/0146645315595585] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
This report provides a review of stem cells/progenitor cells and their responses to ionising radiation in relation to issues relevant to stochastic effects of radiation that form a major part of the International Commission on Radiological Protection's system of radiological protection. Current information on stem cell characteristics, maintenance and renewal, evolution with age, location in stem cell 'niches', and radiosensitivity to acute and protracted exposures is presented in a series of substantial reviews as annexes concerning haematopoietic tissue, mammary gland, thyroid, digestive tract, lung, skin, and bone. This foundation of knowledge of stem cells is used in the main text of the report to provide a biological insight into issues such as the linear-no-threshold (LNT) model, cancer risk among tissues, dose-rate effects, and changes in the risk of radiation carcinogenesis by age at exposure and attained age. Knowledge of the biology and associated radiation biology of stem cells and progenitor cells is more developed in tissues that renew fairly rapidly, such as haematopoietic tissue, intestinal mucosa, and epidermis, although all the tissues considered here possess stem cell populations. Important features of stem cell maintenance, renewal, and response are the microenvironmental signals operating in the niche residence, for which a well-defined spatial location has been identified in some tissues. The identity of the target cell for carcinogenesis continues to point to the more primitive stem cell population that is mostly quiescent, and hence able to accumulate the protracted sequence of mutations necessary to result in malignancy. In addition, there is some potential for daughter progenitor cells to be target cells in particular cases, such as in haematopoietic tissue and in skin. Several biological processes could contribute to protecting stem cells from mutation accumulation: (a) accurate DNA repair; (b) rapidly induced death of injured stem cells; (c) retention of the DNA parental template strand during divisions in some tissue systems, so that mutations are passed to the daughter differentiating cells and not retained in the parental cell; and (d) stem cell competition, whereby undamaged stem cells outcompete damaged stem cells for residence in the niche. DNA repair mainly occurs within a few days of irradiation, while stem cell competition requires weeks or many months depending on the tissue type. The aforementioned processes may contribute to the differences in carcinogenic radiation risk values between tissues, and may help to explain why a rapidly replicating tissue such as small intestine is less prone to such risk. The processes also provide a mechanistic insight relevant to the LNT model, and the relative and absolute risk models. The radiobiological knowledge also provides a scientific insight into discussions of the dose and dose-rate effectiveness factor currently used in radiological protection guidelines. In addition, the biological information contributes potential reasons for the age-dependent sensitivity to radiation carcinogenesis, including the effects of in-utero exposure.
Collapse
|
9
|
Scherthan H, Sotnik N, Peper M, Schrock G, Azizova T, Abend M. Telomere Length in Aged Mayak PA Nuclear Workers Chronically Exposed to Internal Alpha and External Gamma Radiation. Radiat Res 2016; 185:658-67. [DOI: 10.1667/rr14271.1] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
10
|
Fan TM, Khanna C. Comparative Aspects of Osteosarcoma Pathogenesis in Humans and Dogs. Vet Sci 2015; 2:210-230. [PMID: 29061942 PMCID: PMC5644632 DOI: 10.3390/vetsci2030210] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2015] [Revised: 08/01/2015] [Accepted: 08/11/2015] [Indexed: 01/10/2023] Open
Abstract
Osteosarcoma (OS) is a primary and aggressive bone sarcoma affecting the skeleton of two principal species, human beings and canines. The biologic behavior of OS is conserved between people and dogs, and evidence suggests that fundamental discoveries in OS biology can be facilitated through detailed and comparative studies. In particular, the relative genetic homogeneity associated with specific dog breeds can provide opportunities to facilitate the discovery of key genetic drivers involved in OS pathogenesis, which, to-date, remain elusive. In this review, known causative factors that predispose to the development OS in human beings and dogs are summarized in detail. Based upon the commonalities shared in OS pathogenesis, it is likely that foundational discoveries in one species will be translationally relevant to the other and emphasizes the unique opportunities that might be gained through comparative scientific approaches.
Collapse
Affiliation(s)
- Timothy M Fan
- Department of Veterinary Clinical Medicine, Comparative Oncology Research Laboratory, University of Illinois at Urbana-Champaign, Urbana, IL 61820, USA.
| | - Chand Khanna
- Tumor and Metastasis Biology Section, Pediatric Oncology Branch, Center for Clinical Research, The National Cancer Institute, Washington, DC 20004, USA.
| |
Collapse
|
11
|
Suslova KG, Sokolova AB, Efimov AV, Miller SC. Accumulation, organ distribution, and excretion kinetics of ²⁴¹Am in Mayak Production Association workers. HEALTH PHYSICS 2013; 104:313-324. [PMID: 23361427 DOI: 10.1097/hp.0b013e31827c783f] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Americium-241 (²⁴¹Am) is the second most significant radiation hazard after ²³⁹Pu at some of the Mayak Production Association facilities. This study summarizes current data on the accumulation, distribution, and excretion of americium compared with plutonium in different organs from former Mayak PA workers. Americium and plutonium were measured in autopsy and bioassay samples and correlated with the presence or absence of chronic disease and with biological transportability of the aerosols encountered at different workplaces. The relative accumulation of ²⁴¹Am was found to be increasing in the workers over time. This is likely from ²⁴¹Pu that increases with time in reprocessed fuel and from the increased concentrations of ²⁴¹Am and ²⁴¹Pu in inhaled alpha-active aerosols. While differences were observed in lung retention with exposures to different industrial compounds with different transportabilities (i.e., dioxide and nitrates), there were no significant differences in lung retention between americium and plutonium within each transportability group. In the non-pulmonary organs, the highest ratios of ²⁴¹Am/²⁴¹Am + SPu were observed in the skeleton. The relative ratios of americium in the skeleton versus liver were significantly greater than for plutonium. The relative amounts of americium and plutonium found in the skeleton compared with the liver were even greater in workers with documented chronic liver diseases. Excretion rates of ²⁴¹Am in ‘‘healthy’’ workers were estimated using bioassay and autopsy data. The data suggest that impaired liver function leads to reduced hepatic ²⁴¹Am retention, leading to increased ²⁴¹Am excretion.
Collapse
Affiliation(s)
- Klara G Suslova
- Southern Urals Biophysics Institute, Ozyorsk, Chelyabinsk Region, Russia.
| | | | | | | |
Collapse
|
12
|
Mellor FE, Breen AC. Ionizing radiation exposure and the development of intervertebral disc degeneration--no case to answer. Spine J 2013; 13:224-6. [PMID: 23537450 DOI: 10.1016/j.spinee.2012.07.039] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/05/2012] [Accepted: 07/06/2012] [Indexed: 02/03/2023]
Abstract
In the following perspective article, Mellor and Breen provide a counterpoint to a previous perspective on the potential link between ionizing radiation exposure and intervertebral disc degeneration in humans [1]. The previous perspective asked, is this link a myth or reality? It suggested the potential for such a link. Mellor and Breen offer a drastically alternate view, in essence, that the question itself is flawed. To support their perspective, they explain the different units of radiation measurement and their conversion to risk in humans and how this impacts the previous perspective. They explain the variable sensitivity of different body tissues to radiation and highlight that neither human research nor any of the multiple international regulatory agencies have ever suggested that the intervertebral disc is sensitive to radiation. Finally, they claim that it is impossible to predict with any certainty the effects of low-level radiation on the intervertebral discs.
Collapse
Affiliation(s)
- Fiona E Mellor
- Institute for Musculoskeletal Research and Clinical Implementation, Anglo-European College of Chiropractic, 13-15 Parkwood Rd, Bournemouth, BH5 2DF, United Kingdom.
| | | |
Collapse
|
13
|
Berrington de Gonzalez A, Kutsenko A, Rajaraman P. Sarcoma risk after radiation exposure. Clin Sarcoma Res 2012; 2:18. [PMID: 23036235 PMCID: PMC3507855 DOI: 10.1186/2045-3329-2-18] [Citation(s) in RCA: 69] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2011] [Accepted: 02/27/2012] [Indexed: 01/08/2023] Open
Abstract
Sarcomas were one of the first solid cancers to be linked to ionizing radiation exposure. We reviewed the current evidence on this relationship, focusing particularly on the studies that had individual estimates of radiation doses. There is clear evidence of an increased risk of both bone and soft tissue sarcomas after high-dose fractionated radiation exposure (10 + Gy) in childhood, and the risk increases approximately linearly in dose, at least up to 40 Gy. There are few studies available of sarcoma after radiotherapy in adulthood for cancer, but data from cancer registries and studies of treatment for benign conditions confirm that the risk of sarcoma is also increased in this age-group after fractionated high-dose exposure. New findings from the long-term follow-up of the Japanese atomic bomb survivors suggest, for the first time, that sarcomas can be induced by acute lower-doses of radiation (<5 Gy) at any age, and the magnitude of the risk is similar to that observed for other solid cancers. While there is evidence that individuals with certain rare familial genetic syndromes predisposing to sarcoma, particularly Nijmegen Breakage Syndrome, are particularly sensitive to the effects of high dose radiation, it is unclear whether this is also true in very low-dose settings (<0.1 Gy). The effects of common low-penetrance alleles on radiosensitivity in the general population have not been well-characterized. Some evidence suggests that it may be possible to identify radiation-induced sarcomas by a distinct molecular signature, but this work needs to be replicated in several dose settings, and the potential role of chemotherapy and tumor heterogeneity needs to be examined in more detail. In summary, radiation exposure remains one of the few established risk factors for both bone and soft tissue sarcomas. Similar to many other cancers children have the highest risks of developing a radiation-related sarcoma. Efforts to limit unnecessary high-dose radiation exposure, particularly in children, therefore remain important given the high fatality rates associated with this disease.
Collapse
Affiliation(s)
- Amy Berrington de Gonzalez
- Radiation Epidemiology Branch, Division of Cancer Epidemiology & Genetics, NCI/NIH, 6120 Executive Boulevard (Rm 7034), Bethesda, MD 20892, USA.
| | | | | |
Collapse
|
14
|
Fallahian NA, Brey RR, Tivis RD, Piland NF, Simpson DR. Cancer deaths and occupational exposure in a group of plutonium workers. HEALTH PHYSICS 2012; 102:443-452. [PMID: 22378206 DOI: 10.1097/hp.0b013e31823dc308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
An exploratory epidemiological study was conducted for 319 deceased nuclear workers who had intakes of transuranic radionuclides and histories of employment during the time period from 1943 to 1995. The workers were employed at various facilities throughout the United States, including the Department of Energy defense facilities and uranium mining and milling sites. The majority of individuals were involved in documented radiological incidents during their careers. All had voluntarily agreed to donate their organs or whole body to the United States Transuranium and Uranium Registries. External and internal dose assessments were performed using occupational exposure histories and postmortem concentrations of transuranic radionuclides in critical organs. Statistical data analyses were performed to investigate the potential relationship between radiation exposure and causes of death within this population due to cancers of the lungs, liver, and all sites combined while controlling for the effects of other confounders. No association was found between radiation exposure and death due to cancer (α = 0.05). However, statistically significant associations were found between death due to any type of cancer and smoking (yes or no) (odds ratio = 5.41; 95% CI: 1.42 to 20.67) and rate of cigarette smoking (packs per day) (odds ratio = 2.70; 95% CI: 1.37 to 5.30).
Collapse
Affiliation(s)
- Naz Afarin Fallahian
- Bloomsburg University, Department of Physics and Engineering Technology, 400 East 2nd Street, Bloomsburg, PA 17815-1301, USA.
| | | | | | | | | |
Collapse
|
15
|
Suslova KG, Khokhryakov VF, Sokolova AB, Miller SC. 238Pu: a review of the biokinetics, dosimetry, and implications for human exposures. HEALTH PHYSICS 2012; 102:251-262. [PMID: 22420017 DOI: 10.1097/hp.0b013e318234899a] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Plutonium-238 (238Pu) has a half-life of about 87.7 y and thus a higher specific activity than 239Pu. It is used in radioisotope thermoelectric generators and is a substantial source of plutonium alpha-radiation in spent nuclear fuels. Early animal studies demonstrated differences in the biokinetics of inhaled oxides of 238Pu and 239Pu with 238Pu having a substantially more rapid translocation from the lungs to the systemic organs, particularly the skeleton. This resulted in the predominant occurrence of skeletal cancers in animals exposed to 238Pu oxides but lung cancers in those with exposures to 239Pu oxides. The anatomical distribution of osteogenic sarcomas seen in animal studies was similar to that observed with 239Pu and also in plutonium workers but differed from naturally occurring tumors. The in vivo "solubility" of 238Pu has been associated with the relative amounts of 238Pu/239Pu in the particles and calcination temperatures during the preparation of the dioxides. There is experimental evidence of in vivo 238Pu particle fragmentation attributed to nuclear recoil during radioactive decay. The resulting conversion of microparticles to nanoparticles may alter their interactions with macrophages and transport across epithelial barriers. There are few documented cases of human exposures, but the biokinetics appeared to depend on the chemical and physical nature of the aerosols. Robust human biokinetic and dosimetric models have not been developed, due in part to the lack of data. With the acceleration of nuclear technologies and the greater demand for reprocessing and/or disposal of spent nuclear fuels, the potential for human exposure to 238Pu will likely increase in the future.
Collapse
Affiliation(s)
- Klara G Suslova
- Southern Urals Biophysics Institute (SUBI), Ozyorskoe Shosse 19, Ozyorsk, Chelyabinsk Region, Russia.
| | | | | | | |
Collapse
|
16
|
Samartzis D, Cheung KMC. Ionizing radiation exposure and the development of intervertebral disc degeneration in humans: myth or reality. Spine J 2011; 11:979-82. [PMID: 21889418 DOI: 10.1016/j.spinee.2011.07.019] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/07/2011] [Accepted: 07/14/2011] [Indexed: 02/03/2023]
Affiliation(s)
- Dino Samartzis
- Department of Orthopaedics & Traumatology, University of Hong Kong, Pokfulam, Hong Kong, SAR, China.
| | | |
Collapse
|
17
|
Samartzis D, Nishi N, Hayashi M, Cologne J, Cullings HM, Kodama K, Miles EF, Funamoto S, Suyama A, Soda M, Kasagi F. Exposure to ionizing radiation and development of bone sarcoma: new insights based on atomic-bomb survivors of Hiroshima and Nagasaki. J Bone Joint Surg Am 2011; 93:1008-15. [PMID: 21984980 DOI: 10.2106/jbjs.j.00256] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
BACKGROUND Radiation-induced bone sarcoma has been associated with high doses of ionizing radiation from therapeutic or occupation-related exposures. However, the development of bone sarcoma following exposure to lower doses of ionizing radiation remains speculative. METHODS A cohort analysis based on the Life Span Study (n = 120,321) was performed to assess the development of bone sarcoma in atomic-bomb survivors of Hiroshima and Nagasaki followed from 1958 to 2001. The excess relative risk per gray of ionizing radiation absorbed by the bone marrow was estimated. Additional subject demographic, survival, and clinical factors were evaluated. RESULTS Nineteen cases of bone sarcoma (in eleven males and eight females) were identified among the 80,181 subjects who met the inclusion criteria, corresponding to an incidence of 0.9 per 100,000 person-years. The mean ages at the time of the bombing and at diagnosis were 32.4 and 61.6 years, respectively. The mean bone marrow dose was 0.43 Gy. Osteosarcoma was the most commonly identified bone sarcoma. The most common bone sarcoma site was the pelvis. The overall unadjusted five-year survival rate was 25%. A dose threshold was found at 0.85 Gy (95% confidence interval, 0.12 to 1.85 Gy), with a linear dose-response association above this threshold. The linear slope equaled an excess relative risk of 7.5 per Gy (95% confidence interval, 1.34 to 23.14 per Gy) in excess of 0.85 Gy. CONCLUSIONS On the basis of what we believe is one of the longest and largest prospective studies assessing the development of bone sarcoma in individuals exposed to ionizing radiation, it appears that the development of radiation-induced bone sarcoma may be associated with exposure to much lower doses of ionizing radiation than have previously been reported. Such new insights may potentially improve bone sarcoma prevention measures and broaden our understanding of the role of ionizing radiation from various sources on the development of malignant tumors. This study stresses the need to become increasingly aware of the various health risks that may be attributable to even low levels of ionizing radiation exposure. LEVEL OF EVIDENCE Prognostic Level I. See Instructions to Authors for a complete description of levels of evidence.
Collapse
Affiliation(s)
- Dino Samartzis
- Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Arora RS, Kontopantelis E, Alston RD, Eden TO, Geraci M, Birch JM. Relationship between height at diagnosis and bone tumours in young people: a meta-analysis. Cancer Causes Control 2011; 22:681-8. [PMID: 21336591 DOI: 10.1007/s10552-011-9740-9] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2010] [Accepted: 02/01/2011] [Indexed: 10/18/2022]
Abstract
OBJECTIVE Some evidence exists that patients with osteosarcoma and Ewing sarcoma are taller than the general population. However, previous studies are under-powered, lack comprehensive data and show inconsistencies. METHODS Relevant studies linking osteosarcoma and Ewing sarcoma with height at diagnosis were identified in two major online databases, Medline (1950 to 2009) and Embase (1980 to 2009). Outcomes in individual studies were reported as standard deviation (SD) scores or percentages of study population with height at diagnosis above the median of the reference population. We performed separate random-effects meta-analyses for each outcome and tumour type. RESULTS 14 studies examined the height of patients with osteosarcoma or Ewing sarcoma. Meta-analyses on SD scores found patients with osteosarcoma were 0.260 SD (95% CI: 0.088-0.432) taller than the reference population (five studies). A meta-analysis on percentages found 62% (95% CI: 57%-67%) of patients were estimated to have a height above the median (six studies). Patients with Ewing sarcoma were 0.096 SD (95% CI 0.004-0.188) taller (four studies). Only one study reported the percentage of Ewing sarcoma patients with height above the median. CONCLUSION The average height of patients with osteosarcoma, but not Ewing sarcoma, was significantly above the average height of the reference population by 2-3 centimetres. The observed differences indicate the involvement of pubertal longitudinal bone growth in osteosarcoma development while different biological pathways could be relevant for Ewing sarcoma.
Collapse
Affiliation(s)
- Ramandeep S Arora
- Cancer Research UK Paediatric and Familial Cancer Research Group, 1.906, University of Manchester, Stopford Building, Oxford Road, M13 9PL Manchester, UK.
| | | | | | | | | | | |
Collapse
|
19
|
Lyovkina YV, Miller SC, Romanov SA, Krahenbuhl MP, Belosokhov MV. Quantitative plutonium microdistribution in bone tissue of vertebra from a Mayak worker. HEALTH PHYSICS 2010; 99:464-470. [PMID: 20838087 PMCID: PMC2941237 DOI: 10.1097/hp.0b013e3181cb840f] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
The purpose of this study was to obtain quantitative data on plutonium microdistribution in different structural elements of human bone tissue for local dose assessment and dosimetric models validation. A sample of the thoracic vertebra was obtained from a former Mayak worker with a rather high plutonium burden. Additional information was obtained on occupational and exposure history, medical history, and measured plutonium content in organs. Plutonium was detected in bone sections from its fission tracks in polycarbonate film using neutron-induced autoradiography. Quantitative analysis of randomly selected microscopic fields on one of the autoradiographs was performed. Data included fission fragment tracks in different bone tissue and surface areas. Quantitative information on plutonium microdistribution in human bone tissue was obtained for the first time. From these data, the quantitative relationships of plutonium decays in bone volume to decays on bone surface in cortical and trabecular fractions were defined as 2.0 and 0.4, correspondingly. The measured quantitative relationship of decays in bone volume to decays on bone surface does not coincide with recommended models for the cortical bone fraction by the International Commission on Radiological Protection. Biokinetic model parameters of extrapulmonary compartments might need to be adjusted after expansion of the data set on quantitative plutonium microdistribution in other bone types in humans as well as other cases with different exposure patterns and types of plutonium.
Collapse
Affiliation(s)
| | | | - Sergey A. Romanov
- Southern Ural Biophysics Institute, Ozyorsk, Chelabinsk Region, 456780, Russia;
| | | | - Maxim V. Belosokhov
- Southern Ural Biophysics Institute, Ozyorsk, Chelabinsk Region, 456780, Russia;
| |
Collapse
|
20
|
Roch-Lefevre S, Daino K, Altmeyer-Morel S, Guilly MN, Chevillard S. Cytogenetic and molecular characterization of plutonium-induced rat osteosarcomas. JOURNAL OF RADIATION RESEARCH 2010; 51:243-250. [PMID: 20505263 DOI: 10.1269/jrr.09110] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
The association between ionizing radiation and the subsequent development of osteosarcoma has been well described, but little is known about the cytogenetic and molecular events, which could be involved in the formation of radiation-induced osteosarcomas. Here, we performed comparative genomic hybridization (CGH) to detect chromosomal copy number changes in a series of 16 rat osteosarcomas induced by injection of plutonium-238. Recurrent gains/amplifications were observed at chromosomal regions 3p12-q12, 3q41-qter, 4q41-qter, 6q12-q16, 7q22-q34, 8q11-q23, 9q11-q22, 10q32.1-qter, and 12q, whereas recurrent losses were observed at 1p, 1q, 3q23-q35, 5q21-q33, 8q24-q31, 10q22-q25, 15p, 15q, and 18q. The gained region at 7q22-q34 was homologous to human chromosome bands 12q13-q15/8q24/22q11-q13, including the loci of Mdm2, Cdk4, c-Myc and Pdgf-b genes. The lost regions at 5q21-q33, 10q22-q25 and 15q contained tumor suppressor genes such as p16INK4a/p19ARF, Tp53 and Rb1. To identify potential target gene(s) for the chromosomal aberrations, we compared the expression levels of several candidate genes, located within the regions of frequent chromosomal aberrations, between the tumors and normal osteoblasts by using quantitative RT-PCR analysis. The Cdk4, c-Myc, Pdgf-b and p57KIP2 genes were thought to be possible target genes for the frequent chromosomal gain at 7q22-34 and loss at 1q in the tumors, respectively. In addition, mutations of the Tp53 gene were found in 27% (4 of 15) osteosarcomas. Our data may contribute to further understanding of the molecular mechanisms underlying osteosarcomas induced by ionizing radiation in human.
Collapse
|
21
|
Daino K, Roch-Lefevre S, Ugolin N, Altmeyer-Morel S, Guilly MN, Chevillard S. Silencing of Cited2 and Akap12 genes in radiation-induced rat osteosarcomas. Biochem Biophys Res Commun 2009; 390:654-8. [PMID: 19825367 DOI: 10.1016/j.bbrc.2009.10.022] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2009] [Accepted: 10/06/2009] [Indexed: 01/04/2023]
Abstract
We have previously studied genomic copy number changes and global gene expression patterns in rat osteosarcomas (OS) induced by the bone-seeking alpha emitter (238)Pu by comparative genomic hybridization (CGH) and oligonucleotide microarray analyses, respectively. Among the previously identified genes that were down-regulated in radiation-induced rat OS tumors, Cited2 (Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2) and Akap12 (a kinase anchoring protein, also known as src-suppressed C-kinase substrate, SSeCKS) genes mapped to the most frequently lost regions on chromosome 1p. In the present study, relative copy number losses of Cited2 and Akap12 genes were observed in 8 of 15 (53%) and 10 of 15 (67%) tumors by quantitative PCR analysis. Loss of Cited2 and Akap12 in the tumors was confirmed at the levels of mRNA and protein expression by quantitative RT-PCR and immunoblot analyses, respectively. These results indicate that Cited2 and Akap12 are silenced in radiation-induced OS, and therefore are novel candidate tumor-suppressor genes of this tumor.
Collapse
Affiliation(s)
- Kazuhiro Daino
- LCE/iRCM/DSV/CEA, 92265 Fontenay-aux-Roses Cedex, France.
| | | | | | | | | | | |
Collapse
|
22
|
Daino K, Ugolin N, Altmeyer-Morel S, Guilly MN, Chevillard S. Gene expression profiling of alpha-radiation-induced rat osteosarcomas: Identification of dysregulated genes involved in radiation-induced tumorigenesis of bone. Int J Cancer 2009; 125:612-20. [DOI: 10.1002/ijc.24392] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
23
|
Muggenburg BA, Guilmette RA, Hahn FF, Diel JH, Mauderly JL, Seilkop SK, Boecker BB. Radiotoxicity of inhaled (239)PuO(2) in dogs. Radiat Res 2009; 170:736-57. [PMID: 19138039 DOI: 10.1667/rr1409.1] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2008] [Accepted: 07/31/2008] [Indexed: 11/03/2022]
Abstract
Beagle dogs inhaled graded exposure levels of insoluble plutonium dioxide ((239)PuO(2)) aerosols in one of three monodisperse particle sizes at the Lovelace Respiratory Research Institute (LRRI) to study the life-span health effects of different degrees of alpha-particle dose non-uniformity in the lung. The primary noncarcinogenic effects seen were lymphopenia, atrophy and fibrosis of the thoracic lymph nodes, and radiation pneumonitis and pulmonary fibrosis. Radiation pneumonitis/ pulmonary fibrosis occurred from 105 days to more than 11 years after exposure, with the lowest associated alpha-particle dose being 5.9 Gy. The primary carcinogenic effects also occurred almost exclusively in the lung because of the short range of the alpha-particle emissions. The earliest lung cancer was observed at 1086 days after the inhalation exposure. The most common type seen was papillary adenocarcinoma followed by bronchioloalveolar carcinoma. These lung cancer results indicate that a more uniform distribution of alpha-particle dose within the lung has an equal or possibly greater risk of neoplasia than less uniform distributions of alpha-particle dose. The results are consistent with a linear relationship between dose and response, but these data do not directly address the response expected at low dose levels. No primary tumors were found in the tracheobronchial and mediastinal lymph nodes despite the high alpha-particle radiation doses to these lymph nodes, and no cases of leukemia were observed.
Collapse
|
24
|
Boice JD, Bigbee WL, Mumma MT, Tarone RE, Blot WJ. County mortality and cancer incidence in relation to living near two former nuclear materials processing facilities in Pennsylvania--an update. HEALTH PHYSICS 2009; 96:128-137. [PMID: 19131734 DOI: 10.1097/01.hp.0000327664.79349.d4] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
A previous county mortality study of populations living near two nuclear materials processing and fabrication facilities in Westmoreland and Armstrong counties in Pennsylvania (1950-1995) was extended through 2004. Noncancer mortality (1996-2004) and cancer incidence (1990-2004) were also evaluated. Among the Westmoreland and Armstrong populations, 10,547 cancer deaths occurred during the period 1996 through 2004 and the relative risk (RR) based on comparisons with six demographically similar counties in western Pennsylvania was 0.97, that is, almost exactly as expected, and no different from our previously published analyses covering the years 1950-1995. The results based on cancer incidence data were very similar to those based on cancer mortality data. Over the years 1990 though 2004, 39,350 incident cancers were reported among residents of Armstrong and Westmoreland counties and the RR based on the six demographically similar counties was 0.99, that is, almost exactly as expected. The number of deaths from nonmalignant conditions was 36,565 and very close to the number expected (RR 1.01). Overall, no increases in cancer or nonmalignant diseases could be attributed to living in counties with nuclear materials processing and fabrication facilities.
Collapse
Affiliation(s)
- John D Boice
- International Epidemiology Institute, 1455 Research Boulevard, Suite 550, Rockville, MD 20850, USA.
| | | | | | | | | |
Collapse
|
25
|
Kurpinski K, Jang DJ, Bhattacharya S, Rydberg B, Chu J, So J, Wyrobek A, Li S, Wang D. Differential effects of x-rays and high-energy 56Fe ions on human mesenchymal stem cells. Int J Radiat Oncol Biol Phys 2008; 73:869-77. [PMID: 19101095 DOI: 10.1016/j.ijrobp.2008.10.002] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2008] [Revised: 08/29/2008] [Accepted: 09/03/2008] [Indexed: 10/21/2022]
Abstract
PURPOSE Stem cells hold great potential for regenerative medicine, but they have also been implicated in cancer and aging. How different kinds of ionizing radiation affect stem cell biology remains unexplored. This study was designed to compare the biological effects of X-rays and of high-linear energy transfer (LET) (56)Fe ions on human mesenchymal stem cells (hMSC). METHODS AND MATERIALS A multi-functional comparison was carried out to investigate the differential effects of X-rays and (56)Fe ions on hMSC. The end points included modulation of key markers such as p53, cell cycle progression, osteogenic differentiation, and pathway and networks through transcriptomic profiling and bioinformatics analysis. RESULTS X-rays and (56)Fe ions differentially inhibited the cell cycle progression of hMSC in a p53-dependent manner without impairing their in vitro osteogenic differentiation process. Pathway and network analyses revealed that cytoskeleton and receptor signaling were uniquely enriched for low-dose (0.1 Gy) X-rays. In contrast, DNA/RNA metabolism and cell cycle regulation were enriched for high-dose (1 Gy) X-rays and (56)Fe ions, with more significant effects from (56)Fe ions. Specifically, DNA replication, DNA strand elongation, and DNA binding/transferase activity were perturbed more severely by 1 Gy (56)Fe ions than by 1 Gy X-rays, consistent with the significant G2/M arrest for the former while not for the latter. CONCLUSIONS (56)Fe ions exert more significant effects on hMSC than X-rays. Since hMSC are the progenitors of osteoblasts in vivo, this study provides new mechanistic understandings of the relative health risks associated with low- and high-dose X-rays and high-LET space radiation.
Collapse
Affiliation(s)
- Kyle Kurpinski
- Department of Bioengineering, University of California-Berkeley, Berkeley, CA, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Abstract
All of the actinides are radioactive. Taken into the body, they damage and induce cancer in bone and liver, and in the lungs if inhaled, and U(VI) is a chemical kidney poison. Containment of radionuclides is fundamental to radiation protection, but if it is breached accidentally or deliberately, decontamination of exposed persons is needed to reduce the consequences of radionuclide intake. The only known way to reduce the health risks of internally deposited actinides is to accelerate their excretion with chelating agents. Ethylendiaminetetraacetic acid (EDTA) and diethylenetriaminepentaacetic acid (DTPA) were introduced in the 1950's. DTPA is now clinically accepted, but its oral activity is low, it must be injected as a Ca(II) or Zn(II) chelate to avoid toxicity, and it is structurally unsuitable for chelating U(VI) or Np(V). Actinide penetration into the mammalian iron transport and storage systems suggested that actinide ions would form stable complexes with the Fe(III)-binding units found in potent selective natural iron chelators (siderophores). Testing of that biomimetic approach began in the late 1970's with the design, production, and assessment for in vivo Pu(IV) chelation of synthetic multidentate ligands based on the backbone structures and Fe(III)-binding groups of siderophores. New efficacious actinide chelators have emerged from that program, in particular, octadentate 3,4,3-LI(1,2-HOPO) and tetradentate 5-LIO(Me-3,2-HOPO) have potential for clinical acceptance. Both are much more effective than CaNa3-DTPA for decorporation of Pu(IV), Am(III), U(VI), and Np(IV,V), they are orally active, and toxicity is acceptably low at effective dosage.
Collapse
Affiliation(s)
- Patricia W Durbin
- Division of Chemical Sciences, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
| |
Collapse
|
27
|
Sokolnikov ME, Gilbert ES, Preston DL, Ron E, Shilnikova NS, Khokhryakov VV, Vasilenko EK, Koshurnikova NA. Lung, liver and bone cancer mortality in Mayak workers. Int J Cancer 2008; 123:905-11. [PMID: 18528867 DOI: 10.1002/ijc.23581] [Citation(s) in RCA: 84] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Workers at the Mayak nuclear facility in the Russian Federation offer the only adequate human data for evaluating cancer risks from exposure to plutonium. Risks of mortality from cancers of the lung, liver and bone, the organs receiving the largest doses from plutonium, were evaluated in a cohort of 17,740 workers initially hired 1948-1972 using, for the first time, recently improved individual organ dose estimates. Excess relative risk (ERR) models were used to evaluate risks as functions of internal (plutonium) dose, external (primarily gamma) dose, gender, attained age and smoking. By December 31, 2003, 681 lung cancer deaths, 75 liver cancer deaths and 30 bone cancer deaths had occurred. Of these 786 deaths, 239 (30%) were attributed to plutonium exposure. Significant plutonium dose-response relationships (p < 0.001) were observed for all 3 endpoints, with lung and liver cancer risks reasonably described by linear functions. At attained age 60, the ERRs per Gy for lung cancer were 7.1 for males and 15 for females; the averaged-attained age ERRs for liver cancer were 2.6 and 29 for males and females, respectively; those for bone cancer were 0.76 and 3.4. This study is the first to present and compare dose-response analyses for cancers of all 3 organs. The unique Mayak cohort with its high exposures and well characterized doses has allowed quantification of the plutonium dose-response for lung, liver and bone cancer risks based on direct human data. These results will play an important role in plutonium risk assessment.
Collapse
Affiliation(s)
- Mikhail E Sokolnikov
- Southern Urals Biophysics Institute, Ozyorsk, Chelyabinsk Region, Russian Federation
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Abstract
The human hand has been affected by ionizing radiation accidents than any other organ. Hand surgeons should understand the pathophysiology and appropriate management of various types of radiation injury. This article outlines the history and epidemiology of ionizing radiation injury to the hand, basic aspects of radiobiology, and principles of management for injury resulting from fluoroscopy, nuclear accidents or weapons, and other sources.
Collapse
|
29
|
Bijwaard H, Dekkers F. Bone Cancer Risk of239Pu in Humans Derived from Animal Models. Radiat Res 2007; 168:582-92. [DOI: 10.1667/rr0903.1] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2006] [Accepted: 04/27/2007] [Indexed: 11/03/2022]
|
30
|
Kalra S, Grimer RJ, Spooner D, Carter SR, Tillman RM, Abudu A. Radiation-induced sarcomas of bone: factors that affect outcome. ACTA ACUST UNITED AC 2007; 89:808-13. [PMID: 17613509 DOI: 10.1302/0301-620x.89b6.18729] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
We identified 42 patients who presented to our unit over a 27-year period with a secondary radiation-induced sarcoma of bone. We reviewed patient, tumour and treatment factors to identify those that affected outcome. The mean age of the patients at presentation was 45.6 years (10 to 84) and the mean latent interval between radiotherapy and diagnosis of the sarcoma was 17 years (4 to 50). The median dose of radiotherapy given was estimated at 50 Gy (mean 49; 20 to 66). There was no correlation between radiation dose and the time to development of a sarcoma. The pelvis was the most commonly affected site (14 patients (33%)). Breast cancer was the most common primary tumour (eight patients; 19%). Metastases were present at diagnosis of the sarcoma in nine patients (21.4%). Osteosarcoma was the most common diagnosis and occurred in 30 cases (71.4%). Treatment was by surgery and chemotherapy when indicated: 30 patients (71.4%) were treated with the intention to cure. The survival rate was 41% at five years for those treated with the intention to cure but in those treated palliatively the mean survival was only 8.8 months (2 to 22), and all had died by two years. The only factor found to be significant for survival was the ability to completely resect the tumour. Limb sarcomas had a better prognosis (66% survival at five years) than central ones (12% survival at five years) (p = 0.009). Radiation-induced sarcoma is a rare complication of radiotherapy. Both surgical and oncological treatment is likely to be compromised by the treatment received previously by the patient.
Collapse
Affiliation(s)
- S Kalra
- Royal Orthopaedic Hospital, Birmingham, England
| | | | | | | | | | | |
Collapse
|
31
|
Vasilenko EK, Khokhryakov VF, Miller SC, Fix JJ, Eckerman K, Choe DO, Gorelov M, Khokhryakov VV, Knyasev V, Krahenbuhl MP, Scherpelz RI, Smetanin M, Suslova K, Vostrotin V. Mayak worker dosimetry study: an overview. HEALTH PHYSICS 2007; 93:190-206. [PMID: 17693770 DOI: 10.1097/01.hp.0000266071.43137.0e] [Citation(s) in RCA: 78] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
The Mayak Production Association (MPA) was the first plutonium production plant in the former Soviet Union. Workers at the MPA were exposed to relatively large internal radiation intakes and external radiation exposures, particularly in the early years of plant operations. This paper describes the updated dosimetry database, "Doses-2005." Doses-2005 represents a significant improvement in the determination of absorbed organ dose from external radiation and plutonium intake for the original cohort of 18,831 Mayak workers. The methods of dose reconstruction of absorbed organ doses from external radiation uses: 1) archive records of measured dose and worker exposure history, 2) measured energy and directional response characteristics of historical Mayak film dosimeters, and 3) calculated dose conversion factors for Mayak Study-defined exposure scenarios using Monte Carlo techniques. The methods of dose reconstruction for plutonium intake uses two revised models developed from empirical data derived from bioassay and autopsy cases and/or updates from prevailing or emerging International Commission on Radiological Protection models. Other sources of potential significant exposure to workers such as medical diagnostic x-rays, ambient onsite external radiation, neutron radiation, intake of airborne effluent, and intake of nuclides other than plutonium were evaluated to determine their impact on the dose estimates.
Collapse
|
32
|
Bess JD, Krahenbuhl MP, Miller SC, Slaughter DM, Khokhryakov VV, Khokhryakov VF, Suslova KG, Vostrotin VV. Uncertainties analysis for the plutonium dosimetry model, doses-2005, using Mayak bioassay data. HEALTH PHYSICS 2007; 93:207-19. [PMID: 17693771 DOI: 10.1097/01.hp.0000266741.42070.e8] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
The Doses-2005 model is a combination of the International Commission on Radiological Protection (ICRP) models modified using data from the Mayak Production Association cohort. Surrogate doses from inhaled plutonium can be assigned to approximately 29% of the Mayak workers using their urine bioassay measurements and other history records. The purpose of this study was to quantify and qualify the uncertainties in the estimates for radiation doses calculated with the Doses-2005 model by using Monte Carlo methods and perturbation theory. The average uncertainty in the yearly dose estimates for most organs was approximately 100% regardless of the transportability classification. The relative source of the uncertainties comes from three main sources: 45% from the urine bioassay measurements, 29% from the Doses-2005 model parameters, and 26% from the reference masses for the organs. The most significant reduction in the overall dose uncertainties would result from improved methods in bioassay measurement with additional improvements generated through further model refinement. Additional uncertainties were determined for dose estimates resulting from changes in the transportability classification and the smoking toggle. A comparison was performed to determine the effect of using the model with data from either urine bioassay or autopsy data; no direct correlation could be established. Analysis of the model using autopsy data and incorporation of results from other research efforts that have utilized plutonium ICRP models could improve the Doses-2005 model and reduce the overall uncertainty in the dose estimates.
Collapse
Affiliation(s)
- John D Bess
- Center for Excellence in Nuclear Technology, Engineering, and Research (CENTER), 50 So. Central Campus Drive, Rm 1206, University of Utah, Salt Lake City, UT 84112, USA
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Boice JD, Cohen SS, Mumma MT, Dupree Ellis E, Eckerman KF, Leggett RW, Boecker BB, Brill AB, Henderson BE. Mortality among Radiation Workers at Rocketdyne (Atomics International), 1948–1999. Radiat Res 2006; 166:98-115. [PMID: 16808626 DOI: 10.1667/rr3582.1] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
A retrospective cohort mortality study was conducted of workers engaged in nuclear technology development and employed for at least 6 months at Rocketdyne (Atomics International) facilities in California, 1948-1999. Lifetime occupational doses were derived from company records and linkages with national dosimetry data sets. International Commission on Radiation Protection (ICRP) biokinetic models were used to estimate radiation doses to 16 organs or tissues after the intake of radionuclides. Standardized mortality ratios (SMRs) compared the observed numbers of deaths with those expected in the general population of California. Cox proportional hazards models were used to evaluate dose-response trends over categories of cumulative radiation dose, combining external and internal organ-specific doses. There were 5,801 radiation workers, including 2,232 monitored for radionuclide intakes. The mean dose from external radiation was 13.5 mSv (maximum 1 Sv); the mean lung dose from external and internal radiation combined was 19.0 mSv (maximum 3.6 Sv). Vital status was determined for 97.6% of the workers of whom 25.3% (n = 1,468) had died. The average period of observation was 27.9 years. All cancers taken together (SMR 0.93; 95% CI 0.84-1.02) and all leukemia excluding chronic lymphocytic leukemia (CLL) (SMR 1.21; 95% CI 0.69-1.97) were not significantly elevated. No SMR was significantly increased for any cancer or for any other cause of death. The Cox regression analyses revealed no significant dose-response trends for any cancer. For all cancers excluding leukemia, the RR at 100 mSv was estimated as 1.00 (95% CI 0.81-1.24), and for all leukemia excluding CLL it was 1.34 (95% CI 0.73-2.45). The nonsignificant increase in leukemia (excluding CLL) was in accord with expectation from other radiation studies, but a similar nonsignificant increase in CLL (a malignancy not found to be associated with radiation) tempers a causal interpretation. Radiation exposure has not caused a detectable increase in cancer deaths in this population, but results are limited by small numbers and relatively low career doses.
Collapse
Affiliation(s)
- John D Boice
- International Epidemiology Institute, Rockville, Maryland 20850, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
34
|
|
35
|
Boice JD, Leggett RW, Ellis ED, Wallace PW, Mumma M, Cohen SS, Brill AB, Chadda B, Boecker BB, Yoder RC, Eckerman KF. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers. HEALTH PHYSICS 2006; 90:409-30. [PMID: 16607174 DOI: 10.1097/01.hp.0000183763.02247.7e] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
Abstract
Incomplete radiation exposure histories, inadequate treatment of internally deposited radionuclides, and failure to account for neutron exposures can be important uncertainties in epidemiologic studies of radiation workers. Organ-specific doses from lifetime occupational exposures and radionuclide intakes were estimated for an epidemiologic study of 5,801 Rocketdyne/Atomics International (AI) radiation workers engaged in nuclear technologies between 1948 and 1999. The entire workforce of 46,970 Rocketdyne/AI employees was identified from 35,042 Kardex work histories cards, 26,136 electronic personnel listings, and 14,189 radiation folders containing individual exposure histories. To obtain prior and subsequent occupational exposure information, the roster of all workers was matched against nationwide dosimetry files from the Department of Energy, the Nuclear Regulatory Commission, the Landauer dosimetry company, the U.S. Army, and the U.S. Air Force. Dosimetry files of other worker studies were also accessed. Computation of organ doses from radionuclide intakes was complicated by the diversity of bioassay data collected over a 40-y period (urine and fecal samples, lung counts, whole-body counts, nasal smears, and wound and incident reports) and the variety of radionuclides with documented intake including isotopes of uranium, plutonium, americium, calcium, cesium, cerium, zirconium, thorium, polonium, promethium, iodine, zinc, strontium, and hydrogen (tritium). Over 30,000 individual bioassay measurements, recorded on 11 different bioassay forms, were abstracted. The bioassay data were evaluated using ICRP biokinetic models recommended in current or upcoming ICRP documents (modified for one inhaled material to reflect site-specific information) to estimate annual doses for 16 organs or tissues taking into account time of exposure, type of radionuclide, and excretion patterns. Detailed internal exposure scenarios were developed and annual internal doses were derived on a case-by-case basis for workers with committed equivalent doses indicated by screening criteria to be greater than 10 mSv to the organ with the highest internal dose. Overall, 5,801 workers were monitored for radiation at Rocketdyne/AI: 5,743 for external exposure and 2,232 for internal intakes of radionuclides; 41,169 workers were not monitored for radiation. The mean cumulative external dose based on Rocketdyne/AI records alone was 10.0 mSv, and the dose distribution was highly skewed with most workers experiencing low cumulative doses and only a few with high doses (maximum 500 mSv). Only 45 workers received greater than 200 mSv while employed at Rocketdyne/AI. However, nearly 32% (or 1,833) of the Rocketdyne/AI workers had been monitored for radiation at other nuclear facilities and incorporation of these doses increased the mean dose to 13.5 mSv (maximum 1,005 mSv) and the number of workers with >200 mSv to 69. For a small number of workers (n=292), lung doses from internal radionuclide intakes were relatively high (mean 106 mSv; maximum 3,560 mSv) and increased the overall population mean dose to 19.0 mSv and the number of workers with lung dose>200 mSv to 109. Nearly 10% of the radiation workers (584) were monitored for neutron exposures (mean 1.2 mSv) at Rocketdyne/AI, and another 2% were monitored for neutron exposures elsewhere. Interestingly, 1,477 workers not monitored for radiation at Rocketdyne/AI (3.6%) were found to have worn dosimeters at other nuclear facilities (mean external dose of 2.6 mSv, maximum 188 mSv). Without considering all sources of occupational exposure, an incorrect characterization of worker exposure would have occurred with the potential to bias epidemiologic results. For these pioneering workers in the nuclear industry, 26.5% of their total occupational dose (collective dose) was received at other facilities both prior to and after employment at Rocketdyne/AI. In addition, a small number of workers monitored for internal radionuclides contributed disproportionately to the number of workers with high lung doses. Although nearly 12% of radiation workers had been monitored for neutron exposures during their career, the cumulative dose levels were small in comparison with other external and internal exposure. Risk estimates based on nuclear worker data must be interpreted cautiously if internally deposited radionuclides and occupational doses received elsewhere are not considered.
Collapse
Affiliation(s)
- John D Boice
- International Epidemiology Institute, 1455 Research Blvd., Suite 550, Rockville, MD 20850, and Vanderbilt University Medical School and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Suslova KG, Khokhryakov VF, Tokarskaya ZB, Nifatov AP, Sokolova AB, Miller SC, Krahenbuhl MP. Modifying effects of health status, physiological, and dosimetric factors on extrapulmonary organ distribution and excretion of inhaled plutonium in workers at the Mayak Production Association. HEALTH PHYSICS 2006; 90:299-311. [PMID: 16538136 DOI: 10.1097/01.hp.0000183759.39785.9c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
Abstract
This paper summarizes the systemic organ distribution of plutonium in workers exposed by chronic inhalation at the Mayak Production Association (MPA). Using results of radiochemical measurements in soft tissue and bone samples collected at autopsy of 853 autopsy cases, this paper provides data on the effects of various chronic diseases and malignant tumors as well as exposure time, age, sex, and body burden on systemic retention of plutonium in 22 extrapulmonary organs and on the urinary excretion rate of the nuclide. Some aspects of this work have been reported already. The results of present autopsy studies showed that liver pathology accompanied by strong fatty dystrophy of hepatocytes results in a significant relative decrease in the fraction of systemic plutonium in the liver and contravariant increase in the skeletal fraction. The average fractions of systemic plutonium in the liver and the skeleton of those MPA workers were 15% and 75%, respectively, in comparison with 47% and 45% in healthy individuals. Some of the plutonium also redistributed from the liver via blood to other systemic soft tissues. Plutonium not redistributed was excreted with urine. The results of multivariate regression analysis indicated some time-related and sex-related changes not connected with pathology for the liver and the skeleton retention fractions and excretion rate of plutonium. The current ICRP biokinetic models do not account for the influence of different pathological processes in the body on plutonium distribution in systemic organs and urinary excretion. This could have significant consequences for dosimetry calculations and risk estimations.
Collapse
Affiliation(s)
- K G Suslova
- Southern Ural Biophysics Institute, Ozyorskoye shosse 19, Ozyorsk, Chelyabinsk Region, 456780, Russia.
| | | | | | | | | | | | | |
Collapse
|
37
|
Bijwaard H. Mechanistic models of bone cancer induction by radium and plutonium in animals compared to humans. RADIATION PROTECTION DOSIMETRY 2006; 122:340-4. [PMID: 17166879 DOI: 10.1093/rpd/ncl513] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
Two-mutation carcinogenesis models of mice and rats injected with (239)Pu and (226)Ra have been derived extending previous modellings of beagle dogs injected with (239)Pu and (226)Ra and radium dial painters. In all cases statistically significant parameters could be derived fitting data from several research groups jointly. This also lead to similarly parametrised models for (239)Pu and (226)Ra for all species. For each data set not more than five free model parameters were needed to fit the data adequately. From the toxicity ratios of the animal models for (239)Pu and (226)Ra, together with the human model for (226)Ra, an approximate model for the exposure of humans to (239)Pu has been derived. Relative risk calculations with this approximate model are in good agreement with epidemiological findings for the plutonium-exposed Mayak workers. This promising result may indicate new possibilities for estimating risks for humans from animal experiments.
Collapse
Affiliation(s)
- H Bijwaard
- RIVM-National Institute for Public Health and the Environment, Laboratory for Radiation Research, Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands.
| |
Collapse
|
38
|
Miller SC, Liu G, Bruenger FW, Lloyd RD. Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: comparison with injected Zn-DTPA in the rat. RADIATION PROTECTION DOSIMETRY 2006; 118:412-20. [PMID: 16332916 DOI: 10.1093/rpd/nci367] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
Chelators are used to promote excretion of actinides and some other metals, but few are orally effective. The relative efficacies of orally administered triethylenetetraminepentaacetic acids (TT) with varying lipophilic properties on the removal of 241Am and 239Pu and comparison with parenteral Zn-DTPA was determined. The actinides were administered to adult rats 2 weeks prior to initiation of 30 d of chelation treatment. The TT compounds were given orally while Zn-DTPA was given twice weekly by injection. Total body content of 241Am was measured before and during the treatment period and organ contents of 241Am and 239Pu were measured at the end of the study. Significant reductions in 241Am occurred within the first week, with Zn-DTPA being the most effective. By 3 weeks, the most lipophilic chelator, C22TT was as effective as Zn-DTPA. After 30 d, reductions in organ content of 239Pu and 241Am directly correlated with increasing lipophilicity of the TT chelators. Oral C22TT was as effective as injected Zn-DTPA in liver and bone, the major organs of actinide deposition. The removal of 239Pu from the liver and reduction of redeposition of 239Pu in newly formed bone by C22TT was confirmed by neutron-induced autoradiographs. The amphipathic TT chelators may be useful as orally administered alternatives to current parenteral DTPA for the removal of actinide elements from the body, particularly for longer-term therapeutic applications.
Collapse
Affiliation(s)
- Scott C Miller
- Division of Radiobiology, Department of Radiology, University of Utah, 729 Arapeen Drive, Salt Lake City, Utah 84108, USA.
| | | | | | | |
Collapse
|
39
|
Daniels RD, Lodwick CJ, Schubauer-Berigan MK, Spitz HB. Assessment of plutonium exposures for an epidemiological study of US nuclear workers. RADIATION PROTECTION DOSIMETRY 2006; 118:43-55. [PMID: 16081492 DOI: 10.1093/rpd/nci330] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
An ongoing case-control study evaluating the association between workplace external radiation exposures and leukaemia mortality required an assessment of internal plutonium exposures as a potential confounder. Of the study participants, 1,092 were employed at four Department of Energy sites where plutonium-bearing materials were processed or stored. Exposures were assessed by first categorising exposure potentials based on available bioassay data, then estimating doses for workers in the highest categories using recent recommendations of the International Commission on Radiological Protection. Given the aetiology of leukaemia, equivalent dose to active bone marrow was chosen as the exposure variable. There were 556 workers each with at least one plutonium bioassay result, assigned to one of three evaluation categories. Dose estimates were made for 115 workers resulting in a collective equivalent dose of 2.1 person-Sv for 2,822 exposure-years, compared with 29.8 person-Sv estimated from photon exposures. Modelling uncertainties were examined by comparison of results from independent analyses and by Monte Carlo simulation.
Collapse
Affiliation(s)
- R D Daniels
- Division of Surveillance, Hazard Evaluations, and Field Studies, National Institute for Occupational Safety and Health, 5555 Ridge Avenue, R-44 Cincinnati, OH 45213, USA.
| | | | | | | |
Collapse
|
40
|
Bauer S, Gusev BI, Pivina LM, Apsalikov KN, Grosche B. Radiation exposure due to local fallout from Soviet atmospheric nuclear weapons testing in Kazakhstan: solid cancer mortality in the Semipalatinsk historical cohort, 1960-1999. Radiat Res 2005; 164:409-19. [PMID: 16187743 DOI: 10.1667/rr3423.1] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Little information is available on the health effects of exposures to fallout from Soviet nuclear weapons testing and on the combined external and internal environmental exposures that have resulted from these tests. This paper reports the first analysis of the Semipalatinsk historical cohort exposed in the vicinity of the Semipalatinsk nuclear test site, Kazakhstan. The cohort study, which includes 19,545 inhabitants of exposed and comparison villages of the Semipalatinsk region, was set up in the 1960s and comprises 582,750 person-years of follow-up between 1960 and 1999. Cumulative effective radiation dose estimates in this cohort range from 20 mSv to approximately 4 Sv. Rates of mortality and cancer mortality in the exposed group substantially exceeded those of the comparison group. Dose-response analyses within the exposed group confirmed a significant trend with dose for all solid cancers (P < 0.0001) and for digestive and respiratory cancers (P = 0.0255 and P < 0.0001), whereas no consistent dose-response trend was found for all causes of death (P = 0.4296). Regarding specific cancer sites, a significant trend with dose was observed for lung cancer (P = 0.0001), stomach cancer (P = 0.0050), and female breast cancer (P = 0.0040) as well as for esophagus cancer in women (P = 0.0030). The excess relative risk per sievert for all solid cancers combined was 1.77 (1.35; 2.27) based on the total cohort data, yet a selection bias regarding the comparison group could not be entirely ruled out. The excess relative risk per sievert based on the cohort's exposed group was 0.81 (0.46; 1.33) for all solid cancers combined and thus still exceeds current risk estimates from the Life Span Study. Future epidemiological assessments based on this cohort will benefit from extension of follow-up and ongoing validation of dosimetric data.
Collapse
Affiliation(s)
- Susanne Bauer
- Federal Office for Radiation Protection, Institute for Radiation Hygiene, Germany.
| | | | | | | | | |
Collapse
|
41
|
Hande MP, Azizova TV, Burak LE, Khokhryakov VF, Geard CR, Brenner DJ. Complex chromosome aberrations persist in individuals many years after occupational exposure to densely ionizing radiation: an mFISH study. Genes Chromosomes Cancer 2005; 44:1-9. [PMID: 15912529 DOI: 10.1002/gcc.20217] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Long-lived, sensitive, and specific biomarkers of particular mutagenic agents are much sought after and potentially have broad applications in the fields of cancer biology, epidemiology, and prevention. Many clastogens induce a spectrum of chromosome aberrations, and some of them can be exploited as biomarkers of exposure. Densely ionizing radiation, for example, alpha particle radiation (from radon or plutonium) and neutron radiation, preferentially induces complex chromosome aberrations, which can be detected by the 24-color multifluor fluorescence in situ hybridization (mFISH) technique. We report the detection and quantification of stable complex chromosome aberrations in lymphocytes of healthy former nuclear-weapons workers, who were exposed many years ago to plutonium, gamma rays, or both, at the Mayak weapons complex in Russia. We analyzed peripheral-blood lymphocytes from these individuals for the presence of persistent complex chromosome aberrations. A significantly elevated frequency of complex chromosome translocations was detected in the highly exposed plutonium workers but not in the group exposed only to high doses of gamma radiation. No such differences were found for simple chromosomal aberrations. The results suggest that stable complex chromosomal translocations represent a long-lived, quantitative, low-background biomarker of densely ionizing radiation for human populations exposed many years ago.
Collapse
Affiliation(s)
- M Prakash Hande
- Center for Radiological Research, Columbia University Medical Center, New York, USA
| | | | | | | | | | | |
Collapse
|
42
|
Leggett RW, Eckerman KF, Khokhryakov VF, Suslova KG, Krahenbuhl MP, Miller SC. Mayak worker study: an improved biokinetic model for reconstructing doses from internally deposited plutonium. Radiat Res 2005; 164:111-22. [PMID: 16038582 DOI: 10.1667/rr3371] [Citation(s) in RCA: 103] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The plutonium production facility known as the Mayak Production Association was put into operation in June 1948. A high incidence of cancer in the Mayak workers has been related to the level of exposure to plutonium, but uncertainties in tissue doses have hampered development of dose-risk relationships. As part of an effort to improve dose estimates for these workers, the systemic biokinetic model for plutonium currently recommended by the International Commission on Radiological Protection (ICRP) has been modified to reflect recently developed data and facilitate interpretation of case-specific information. This paper describes the proposed model and discusses its implications for dose reconstruction for the Mayak workers.
Collapse
Affiliation(s)
- R W Leggett
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA.
| | | | | | | | | | | |
Collapse
|
43
|
|
44
|
Gilbert ES, Koshurnikova NA, Sokolnikov ME, Shilnikova NS, Preston DL, Ron E, Okatenko PV, Khokhryakov VF, Vasilenko EK, Miller S, Eckerman K, Romanov SA. Lung cancer in Mayak workers. Radiat Res 2005; 162:505-16. [PMID: 15624305 DOI: 10.1667/rr3259] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The cohort of nuclear workers at the Mayak Production Association, located in the Russian Federation, is a unique resource for providing information on the health effects of exposure to plutonium as well as the effects of protracted external dose. Lung cancer mortality risks were evaluated in 21,790 Mayak workers, a much larger group than included in previous evaluations of lung cancer risks in this cohort. These analyses, which included 655 lung cancer deaths occurring in the period 1955-2000, were the first to evaluate both excess relative risk (ERR) and excess absolute risk (EAR) models and to give detailed attention to the modifying effects of gender, attained age and age at hire. Lung cancer risks were found to be significantly related to both internal dose to the lung from plutonium and external dose, and risks were described adequately by linear functions. For internal dose, the ERR per gray for females was about four times higher than that for males, whereas the EAR for females was less than half that for males; the ERR showed a strong decline with attained age, whereas the EAR increased with attained age until about age 65 and then decreased. Parallel analyses of lung cancer mortality risks in Mayak workers and Japanese A-bomb survivors were also conducted. Efforts currently under way to improve both internal and external dose estimates, and to develop data on smoking, should result in more accurate risk estimates in the future.
Collapse
Affiliation(s)
- E S Gilbert
- Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20852, USA.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Bijwaard H, Brugmans MJP, Leenhouts HP. Two-mutation models for bone cancer due to radium, strontium and plutonium. Radiat Res 2004; 162:171-84. [PMID: 15387145 DOI: 10.1667/rr3184] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Data from beagle experiments and radium dial painters were used to derive two-mutation carcinogenesis models for bone cancer induced by the bone-seeking radionuclides radium, strontium and plutonium. For all data, the model fits indicate that at low doses both mutation rates depend linearly and equally strongly on dose rate. For the high-LET alpha-particle emitters, a cell killing term reduces the second mutation rate at high dose rates. In all cases, the combined effect of both mutation rates is a linear-quadratic dose-effect relationship for cancer at low doses. This behavior may lead to experimental data that could be mistaken as showing a threshold below which no cancers are induced. Derived parameters such as toxicity ratios and tumor growth times compare well with values reported in the literature. Furthermore, results for plutonium indicate that rapid burial of the nuclide in the growing bones of juvenile beagles leads to a significant reduction of its toxicity, as was suggested previously. The results for radium in beagles compare well with those for humans and suggest that the models derived for strontium and plutonium in beagles may be translated to humans. The significant model parameters for the accurate animal data could then also be used to fit human epidemiological data.
Collapse
Affiliation(s)
- Harmen Bijwaard
- Laboratory for Radiation Research, RIVM, Bilthoven, The Netherlands.
| | | | | |
Collapse
|
46
|
Abstract
Ionizing radiation has been the subject of intense epidemiological investigation. Studies have demonstrated that exposure to moderate-to-high levels can cause most forms of cancer, leukaemia and cancers of the breast, lung and thyroid being particularly sensitive to induction by radiation, especially at young ages at exposure. Predominant among these studies is the Life Span Study of the cohort of survivors of the atomic bombings of Japan in 1945, but substantial evidence is derived from groups exposed for medical reasons, occupationally or environmentally. Notable among these other groups are underground hard rock miners who inhaled radioactive radon gas and its decay products, large numbers of patients irradiated therapeutically and workers who received high doses in the nuclear weapons programme of the former USSR. The degree of carcinogenic risk arising from low levels of exposure is more contentious, but the available evidence points to an increased risk that is approximately proportional to the dose received. Epidemiological investigations of nonionizing radiation have established ultraviolet radiation as a cause of skin cancer. However, the evidence for a carcinogenic effect of other forms of nonionizing radiation, such as those associated with mobile telephones or electricity transmission lines, is not convincing, although the possibility of a link between childhood leukaemia and extremely low-frequency electromagnetic fields cannot be dismissed entirely.
Collapse
|
47
|
Brown SC, Schonbeck MF, McClure D, Barón AE, Navidi WC, Byers T, Ruttenber AJ. Lung cancer and internal lung doses among plutonium workers at the Rocky Flats Plant: a case-control study. Am J Epidemiol 2004; 160:163-72. [PMID: 15234938 DOI: 10.1093/aje/kwh192] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
The authors conducted a nested case-control study of the association between lung cancer mortality and cumulative internal lung doses among a cohort of workers employed at the Rocky Flats Plant in Colorado from 1951 to 1989. Cases (n = 180) were individually matched with controls (n = 720) on age, sex, and birth year. Annual doses to the lung from plutonium, americium, and uranium isotopes were calculated for each worker with an internal dosimetry model. Lung cancer risk was elevated among workers with cumulative internal lung doses of more than 400 mSv in several different analytical models. The dose-response relation was not consistent at high doses. Restricting analysis to those employed for 15-25 years produced a statistically significant linear trend with dose (chi-square = 67.2, p < 0.001), suggesting a strong healthy worker survivor effect. The association between age at first internal lung dose and lung cancer mortality was statistically significant (odds ratio = 1.05, 95% confidence interval: 1.01, 1.10). No associations were found between lung cancer mortality and cumulative external penetrating radiation dose or cumulative exposures to asbestos, beryllium, hexavalent chromium, or nickel.
Collapse
Affiliation(s)
- Shannon C Brown
- Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
| | | | | | | | | | | | | |
Collapse
|
48
|
Travis LB, Hauptmann M, Gaul LK, Storm HH, Goldman MB, Nyberg U, Berger E, Janower ML, Hall P, Monson RR, Holm LE, Land CE, Schottenfeld D, Boice JD, Andersson M. Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast. Radiat Res 2004; 160:691-706. [PMID: 14640794 DOI: 10.1667/rr3095] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Few opportunities exist to evaluate the carcinogenic effects of long-term internal exposure to alpha-particle-emitting radionuclides. Patients injected with Thorotrast (thorium-232) during radiographic procedures, beginning in the 1930s, provide one such valuable opportunity. We evaluated site-specific cancer incidence and mortality among an international cohort of 3,042 patients injected during cerebral angiography with either Thorotrast (n = 1,650) or a nonradioactive agent (n = 1,392) and who survived 2 or more years. Standardized incidence ratios (SIR) for Thorotrast and comparison patients (Denmark and Sweden) were estimated and relative risks (RR), adjusted for population, age and sex, were generated with multivariate statistical modeling. For U.S. patients, comparable procedures were used to estimate standardized mortality ratios (SMR) and RR, representing the first evaluation of long-term, site-specific cancer mortality in this group. Compared with nonexposed patients, significantly increased risks in Thorotrast patients were observed for all incident cancers combined (RR = 3.4, 95% CI 2.9-4.1, n = 480, Denmark and Sweden) and for cancer mortality (RR = 4.0, 95% CI 2.5-6.7, n = 114, U.S.). Approximately 335 incident cancers were above expectation, with large excesses seen for cancers of the liver, bile ducts and gallbladder (55% or 185 excess cancers) and leukemias other than CLL (8% or 26 excess cancers). The RR of all incident cancers increased with time since angiography (P < 0.001) and was threefold at 40 or more years; significant excesses (SIR = 4.0) persisted for 50 years. Increasing cumulative dose of radiation was associated with an increasing risk of all incident cancers taken together and with cancers of the liver, gallbladder, and peritoneum and other digestive sites; similar findings were observed for U.S. cancer mortality. A marginally significant dose response was observed for the incidence of pancreas cancer (P = 0.05) but not for lung cancer. Our study confirms the relationship between Thorotrast and increased cancer incidence at sites of Thorotrast deposition and suggests a possible association with pancreas cancer. After injection with >20 ml Thorotrast, the cumulative excess risk of cancer incidence remained elevated for up to 50 years and approached 97%. Caution is needed in interpreting the excess risks observed for site-specific cancers, however, because of the potential bias associated with the selection of cohort participants, noncomparability with respect to the internal or external comparison groups, and confounding by indication. Nonetheless, the substantial risks associated with liver cancer and leukemia indicate that unique and prolonged exposure to alpha-particle-emitting Thorotrast increased carcinogenic risks.
Collapse
Affiliation(s)
- Lois B Travis
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland 20892, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Boice JD, Bigbee WL, Mumma MT, Blot WJ. Cancer incidence in municipalities near two former nuclear materials processing facilities in Pennsylvania. HEALTH PHYSICS 2003; 85:678-690. [PMID: 14626319 DOI: 10.1097/00004032-200312000-00013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Because nuclear facilities can release radionuclides into the surrounding environment accidentally or during normal operations, there has been public concern over the possibility of adverse health effects. Two former nuclear materials processing facilities in Armstrong County Pennsylvania have been the focus of such public concern for over 20 y. The Apollo and Parks facilities processed uranium and plutonium fuels for use in nuclear applications. To evaluate the possibility of increased cancer rates in the communities near the Apollo-Parks nuclear processing materials plants, cancer incidence rates were assessed for the years 1993-1997, or nearly 40 y after the plants had begun operation in 1957 and 1960, respectively. The rates of cancer were evaluated among the approximately 17,000 persons living in 1 of 8 municipalities encompassing or near these nuclear sites. Numbers of cancers and mailing addresses (n = 935) were obtained from the Pennsylvania Department of Health. Because mailing addresses in small rural areas do not always reflect actual residences within a municipality, each of 935 addresses was validated (and corrections made when indicated) by contacting area postmasters and using Census Bureau geocoding information, street maps, and aerial photographs. Standardized Incidence Ratios (SIRs) were computed as the ratio of observed numbers of cancers in the study area compared to the expected number derived from general population rates of Pennsylvania. Forty percent of the mailing addresses were found not to be within the boundaries of the study municipalities. After excluding these persons who did not reside in one of the eight municipalities near the Apollo-Parks facilities, 581 cancers remained in contrast to 574.0 expected (SIR 1.01; 95% confidence interval 0.93-1.10). Based upon knowledge of the tissues where uranium or plutonium likely would be deposited after intake, cancers of the lung (SIR 0.88), kidney (SIR 1.05), non-Hodgkin's lymphoma (SIR 1.10), liver (SIR 0.61), and bone (2 observed vs. 1.19 expected) were carefully evaluated, but no significant excesses were noted at these sites. Cancers of the female breast and thyroid and leukemia also were not significantly increased, as expected since these tissues are not sites where uranium or plutonium would concentrate. Overall, no increase in cancer risk could be attributed to living near the two former nuclear materials processing facilities. However, misleading elevations in cancer risks would have been suggested if mailing addresses had not been corrected to exclude addresses that were not within the boundaries of the municipalities for which population data were available. The study had sufficient power to exclude increased cancer risks of 10% or greater.
Collapse
Affiliation(s)
- John D Boice
- International Epidemiology Institute, 1455 Research Blvd, Suite 550, Rockville, MD 20850, USA.
| | | | | | | |
Collapse
|
50
|
Miller SC, Lloyd RD, Bruenger FW, Krahenbuhl MP, Polig E, Romanov SA. Comparisons of the Skeletal Locations of Putative Plutonium-Induced Osteosarcomas in Humans with those in Beagle Dogs and with Naturally Occurring Tumors in both Species. Radiat Res 2003; 160:517-23. [PMID: 14565831 DOI: 10.1667/rr3072] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Osteosarcomas occur from exposures to bone-seeking, alpha-particle-emitting isotopes, particularly plutonium. The skeletal distribution of putative 239Pu-induced osteosarcomas reported in Mayak Metallurgical and Radiochemical Plutonium Plant workers is compared with those observed in canine studies, and these are compared with distributions of naturally occurring osteosarcomas in both species. In the Mayak workers, 29% and 71% of the osteosarcomas were in the peripheral and central skeleton, respectively, with the spine having the most tumors (36%). An almost identical distribution of plutonium-induced osteosarcomas was reported for dogs injected with 239Pu as young adults. This distribution of osteosarcomas is quite different from the distributions of naturally occurring osteosarcomas for both species. In the Cooperative Osteosarcoma Study Group in humans (1,736 osteosarcomas from all ages), over 91% of the tumors occurred in the peripheral skeleton. In the Mayo Clinic group of older individuals (>40 years old), over 60% of the osteosarcomas appeared in the peripheral skeleton. The distribution of naturally occurring osteosarcomas in the canine is similar to that in the adult human. The similarities of the distributions of plutonium-associated osteosarcomas in the Mayak workers with those found in experimental studies suggest that many of the reported osteosarcomas may have been associated with plutonium exposures. These results also support the experimental paradigm that plutonium osteosarcomas have a preference for well vascularized cancellous bone sites. These sites have a greater initial deposition of plutonium, but also greater turnover due to elevated bone remodeling rates.
Collapse
Affiliation(s)
- Scott C Miller
- Division of Radiobiology, Department of Radiology, University of Utah, Salt Lake City, Utah 84108, USA.
| | | | | | | | | | | |
Collapse
|